MOTS-c 60mg Mitochondrial-Derived Peptide

MOTS-c is an investigational mitochondrial-derived peptide being studied for its role in cellular energy metabolism, metabolic signalling and stress-response pathways. Research has explored its potential involvement in insulin sensitivity, glucose metabolism, exercise-related adaptation and mitochondrial function.

Research areas include: metabolic health, glucose and insulin signalling, cellular energy metabolism, mitochondrial function, exercise adaptation and healthy-aging research. A Phase 2a human clinical trial is currently investigating MOTS-c in adults with prediabetes and overweight/obesity, with insulin sensitivity and metabolic markers among the study outcomes.

Important: MOTS-c is an investigational compound and is not approved for general human use. This product is provided for research purposes only and is not intended to diagnose, treat, cure or prevent any disease or medical condition.

The Certificate of Analysis for lot GX-2026 confirms an HPLC purity of 99%+ and identity confirmed by mass spectrometry.

The Safety Data Sheet describes handling, storage and disposal information for this research compound. Always follow standard laboratory safety practice.